

Page 51
conferenceseries
.com
Volume 6, Issue 5 (Suppl)
J Pain Relief, an open access journal
ISSN: 2167-0846
Pain Management 2017
October 05-06, 2017
5
th
International Conference and Exhibition on
October 05-06, 2017 London, UK
Pain Research And Management
Stability and change in fibromyalgia symptoms: A 2-year longitudinal study
Ann Vincent
1
, Kelly Kennedy
2
, Mary Whipple
3
and
Loren Toussaint
2
1
Mayo Clinic, Rochester, USA
2
Luther College, USA
3
University of Minnesota School of Nursing, USA
Background & Aim:
Fibromyalgia is musculoskeletal pain disorder that impacts well-being and interrupts daily activities. The
present study evaluated the stability and change of key fibromyalgia symptoms over a 2-year period.
Methods:
Patients from an existing fibromyalgia registry were mailed seven validated questionnaires evaluating physical
functioning, fatigue, daily limitations, pain, sleep levels, mental and physical well-being, and cognitive abilities. Of the 1303
patients contacted, 858 returned a completed survey. Approximately two years later, the patients who completed the baseline
survey were sent a second and identical survey. A total of 450 patients returned the follow-up survey and are included in these
analyses.
Results:
Paired t-tests showed a significant change in fibromyalgia impact, fatigue, mental and physical health, pain, mood, and
cognitive abilities (ps<.05) over the two-year period. Statistically larger decreases in mental health and increases in pain, as well
as, vitality were observed. The remainder of the changes, while statistically significant, was smaller.
Conclusions:
Although the results of our study suggest a slight trend toward improvement in several of the measures, changes
were small to modest in size; and not significant according to minimum clinically significant difference (MCID) criteria over
the two years of this study. Our study sheds light on the longer-term prognosis for worsening or improving symptoms in
fibromyalgia. Specifically, our findings suggest that the long-term trajectory for change, in either direction, is considerably
more stable and unchanging than existing research might suggest.
vincent.ann@mayo.eduJ Pain Relief 2017, 6:5(Suppl)
DOI: 10.4172/2167-0846-C1-015